USFDA completes audit at Dr. Reddy’s CPS facility in Telangana

21 Sep 2017 Evaluate

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy’s Laboratories’ Custom Pharmaceutical Services (CPS) facility, Technology Development Centre (TDC-1) at Miyapur, Hyderabad, Telangana with Zero observations on September 21, 2017.

Earlier, the USFDA had completed the inspection at Dr. Reddy’s Laboratories’ API Mirfield Plant, United Kingdom on September 15, 2017.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1270.50 19.40 (1.55%)
11-Dec-2025 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.95
Dr. Reddys Lab 1270.50
Cipla 1501.55
Zydus Lifesciences 921.10
Lupin 2072.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×